Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia

Cardiovascular risk in heterozygous familial hypercholesterolaemia (HeFH) is driven by LDL cholesterol levels. Since lipid response to statin therapy presents individual variation, this study aimed to compare mean LDL and non-HDL cholesterol reductions and their variability achieved with different types and doses of the most frequently prescribed statins.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - January 28, 2021 Category: Nutrition Authors: Elisenda Climent, Victoria Marco-Bened í, David Benaiges, Xavier Pintó, Manuel Suárez-Tembra, Núria Plana, Hannia Lafuente, Emilio Ortega-Martínez de Victoria, Ángel Brea-Hernando, Àlex Vila, Fernando Civeira, Juan Pedro-Botet Source Type: research